Clinical Trials, Drug Manufacturers

Pharmaceutical Services

By Micromeritics

Understanding physiochemical properties of drug substances, excipients,and finished products is crucial.

In today's age of Process Analytical Technology (PAT) and Quality by Design (QbD), regulatory authorities look favourably on drug development parterships with contract research organisations (CROs) that have specific areas of expertise in material charaterisation.

Download to find out more.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.